LNC
50
-8
ROST
49
-3
EBAY
45
-2
LEN
11
-3
FIS
72
-5
LOW
36
-13
HSIC
51
-2
NOV
45
-5
SNA
45
-4
AAP
33
-3
WYNN
30
-6
PHM
47
-8
WAT
43
-4
AMZN
49
-6
EXPE
70
-2
CAT
43
-5
ROP
62
-3
ETN
46
-6
PH
60
-7
GT
30
-4
LNC
50
-8
ROST
49
-3
EBAY
45
-2
LEN
11
-3
FIS
72
-5
LOW
36
-13
HSIC
51
-2
NOV
45
-5
SNA
45
-4
AAP
33
-3
WYNN
30
-6
PHM
47
-8
WAT
43
-4
AMZN
49
-6
EXPE
70
-2
CAT
43
-5
ROP
62
-3
ETN
46
-6
PH
60
-7
GT
30
-4
Financhill
Back

Givaudan SA Vs. Royalty Pharma PLC Industry Stock Comparison

Buy
68

GVDNY
Givaudan SA

Last Price:
$86.89
Seasonality Move:
4.79%
Sell
28

RPRX
Royalty Pharma PLC

Last Price:
$31.38
Seasonality Move:
-2.74%
Buy
68
Givaudan SA (GVDNY) is a Buy

Is Givaudan SA a Buy, Sell or Hold?

  • The current Givaudan SA [GVDNY] share price is $86.89. The Score for GVDNY is 68, which is 36% above its historic median score of 50, and infers lower risk than normal.
  • GVDNY is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
28
Royalty Pharma PLC (RPRX) is a Sell

Is Royalty Pharma PLC a Buy, Sell or Hold?

  • The current Royalty Pharma PLC [RPRX] share price is $31.37. The Score for RPRX is 28, which is 44% below its historic median score of 50, and infers higher risk than normal.
  • RPRX is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

GVDNY Stock Price Chart

What is Givaudan SA's stock price today?

  • The Givaudan SA share price today is $86.89
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and GVDNY is experiencing slight buying pressure.

RPRX Stock Price Chart

What is Royalty Pharma PLC's stock price today?

  • The Royalty Pharma PLC share price today is $31.37
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and RPRX is experiencing slight selling pressure.

GVDNY Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.46 Sell
Relative Strength Index (14 RSI): 44.56 Sell
Chaikin Money Flow: 8182 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (87.23 - 91.19) Sell
Bollinger Bands (100): (85.77 - 90.73) Sell

RPRX Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.03 Sell
Relative Strength Index (14 RSI): 35.44 Sell
Chaikin Money Flow: -282065 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (32.41 - 33.81) Sell
Bollinger Bands (100): (26.01 - 32.63) Buy

GVDNY Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 87.84 Sell
20-day SMA: 89.44 Sell
50-day SMA: 87.88 Sell
200-day SMA: 94.01 Sell
8-day EMA: 87.45 Sell
20-day EMA: 88.41 Sell
50-day EMA: 88.54 Sell
200-day EMA: 90.12 Sell

RPRX Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 32.84 Sell
20-day SMA: 32.99 Sell
50-day SMA: 32.42 Sell
200-day SMA: 28.45 Buy
8-day EMA: 32.44 Sell
20-day EMA: 32.75 Sell
50-day EMA: 31.89 Sell
200-day EMA: 29.45 Buy

Givaudan SA Earnings Growth & GVDNY Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Royalty Pharma PLC Earnings Growth & RPRX Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.25 per share, an increase next quarter of $0.18 per share, an increase this year of $0.62 per share, and an increase next year of $0.31 per share.

Givaudan SA Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Royalty Pharma PLC Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):